May 08, 2024

S&P 500 Encounters Resistance After Sustained Gains: Market Overview

Wall Street’s enthusiasm waned after a four-day streak that propelled the market to its most extended winning sequence since March. The S&P 500 fluctuated, struggling to surpass the 5,200 level it briefly achieved earlier this week. Notable declines in megacaps were led by Nvidia Corp. ( $NVDA) and Tesla Inc. ( $TSLA). Uber Technologies Inc…. [Read More]
Beautiful senior woman smiles while walking for breast cancer awareness
May 07, 2024

IceCure’s ProSense® Demonstrates “Zero Local Recurrence” of Breast Cancer

IceCure Medical (Nasdaq: ICCM) saw its share price rise by 1.75% in intraday trading on Tuesday after the company announced that results from an independent study of patients in Japan demonstrated zero local recurrence of breast cancer five years after treatment with the company’s ProSense® cryoablation device. The study of 18 early-stage breast cancer patients… [Read More]
Elegant and luxury interior design of beauty cosmetic shop with wooden and gold shelf, pastel green cabinet and display in cream beige wall and decorative mirror and light for product display background
May 07, 2024

Beauty Centric Business Shows Strength as Coty (COTY) Announces Earnings

The beauty product manufacturer Coty, Inc. (COTY) announced Q3 earnings yesterday, after the close. The company came in just shy on Q3 EPS $0.05 vs FactSet $0.06 but beat on revenues $1.39B vs FactSet 1.37B and adjusted EBITDA $199.9M vs FactSet $194.2M. The real beauty of its report was on FY guidance as Coty expects… [Read More]
May 07, 2024

Stock Market Rally Continues Amid Bank Earnings and Rate Cut Hopes

Stocks have rallied for a fourth consecutive day, fueled by optimism over potential Federal Reserve rate cuts and solid earnings reports. This upward trend has propelled the US equity benchmark past a key technical threshold, though it’s still uncertain if this momentum can sustain given the various economic factors at play. Investors remain divided, with… [Read More]
May 07, 2024

Lipella Pharmaceuticals Advances With Multiple Near-Term Catalysts and Strategic Focus on Rare Diseases

Lipella Pharmaceuticals (Nasdaq: LIPO) is making significant strides with its innovative liposomal delivery technologies and targeted therapies for oral mucosa and bladder conditions. As it enters a period rich with clinical and strategic milestones, the company’s focus remains on rare and orphan indications, featuring a de-risked pipeline of promising candidates positioned for pivotal developments. De-risked… [Read More]
May 07, 2024

Prism Stocks making the biggest moves premarket: Walt Disney, Hims & Hers, Palantir and more

Don’t miss the companies making waves before the market opens: Walt Disney — Despite beating fiscal second-quarter earnings expectations, the media titan saw its shares decrease by over 4%, even with reduced streaming losses. Hims & Hers Health — Following an impressive second-quarter revenue guidance surpassing estimates, the telehealth consultation platform saw a 14% surge… [Read More]
May 06, 2024

Oncocyte: Disrupting the Precision Diagnostics Marketplace with Innovative Approach to Growth

About Oncocyte Oncocyte is a precision diagnostics company. The Company’s tests are designed to help provide clarity and confidence to physicians and their patients. VitaGraft™ is a clinical blood-based solid organ transplantation monitoring test, GraftAssure™ is a research use only blood-based solid organ transplantation monitoring test, DetermaIO™ is a gene expression test that assesses the… [Read More]
May 06, 2024

S&P 500 ( $SPX) Set for Stellar Three-Day Rally in 2024: Market Overview

US stocks are continuing their rebound, marking a third consecutive session of gains. Amid expectations that the Federal Reserve may reduce interest rates this year and signs that geopolitical tensions are easing, the markets are experiencing their most substantial rally of 2024. The S&P 500 has surpassed its 50-day average price, a critical level for… [Read More]
May 06, 2024

Gossamer Enters Global Collaboration and License Agreement Valued at $486M

Biopharmaceutical company Gossamer Bio (Nasdaq: GOSS) has entered a global collaboration and license agreement with the Chiesi Farmaceutici S.p.A (Chiesi Group), an international, research-focused biopharmaceutical group. Together, the companies will develop and commercialize seralutinib, an inhaled dry powder treatment for the potential treatment of pulmonary hypertension and interstitial lung disease (PH-ILD). The company’s share price… [Read More]
May 06, 2024

SoundHound AI, Inc. Raises Volume

When it comes to the world of AI technology, SoundHound AI (NASDAQ:SOUN) stands out due to its unique focus on voice applications. The stock may be an attractive prospect for investors bullish on AI and willing to embrace inherent risks and rewards. This AI giant has an upcoming event that you need to be aware… [Read More]